How will your body react after you stop taking Tazemetostat?
Tazemetostat is an oral tyrosine kinase inhibitor used to treat certain types of cancer, such as hairy cell leukemia and other lymphomas. Because it is a targeted drug, its main effect is to inhibit the proliferation of cancer cells caused by EZH2 gene mutations. For patients taking tazerestat, the body may experience some reactions once the drug is stopped, and the specific reactions vary depending on the individual patient.
Tazetostat helps slow the progression of cancer by inhibiting the proliferation of tumor cells. Therefore, patients may be at risk of a recurrence of their cancer after stopping the drug. This is because after the drug is stopped, tumor cells in the body may resume proliferation, especially when the patient's tumor is highly dependent on the drug. The tumor may relapse quickly within a few months after drug withdrawal. Patients may experience a return of symptoms such as weight loss, fatigue, and pain.
After tazetostat is stopped, the drug is gradually eliminated from the body, usually over days to weeks. Side effects may lessen or disappear during drug elimination, especially when the drug stops working, and patients may experience some physical recovery, such as increased appetite and restored energy. However, it is also possible that due to the rebound effect of the tumor, the patient will experience some worsening symptoms again, which requires communication with the doctor to evaluate whether treatment needs to be restarted.
Some patients may experience discontinuation syndrome-like symptoms after stopping the drug. These symptoms are often related to the mechanism of action of the drug and may manifest as mood swings, fatigue, feelings of weakness, etc. Although rare, some adaptive responses by the body after discontinuation of anticancer drugs are possible in patients who have been taking anticancer drugs for a long time. If the patient experiences severe discomfort, it is recommended to consult a doctor promptly to find out whether other medications are needed to help control symptoms.
Reference materials:https://www.tazverik.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)